{"entity":{"id":"nct02496065","kind":"trial","name":"Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery","aka":[],"tldr":"A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., completed.","summary":"Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery is a phase 1 interventional study registered as NCT02496065 by Blaze Bioscience Inc., with 30 participants enrolled, started 2015-07. Conditions recorded: Tumors, Breast. Interventions recorded: BLZ-100.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT02496065","url":"https://clinicaltrials.gov/study/NCT02496065"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["blz-100"],"companies":["blaze-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02496065","phase":"1","setting":"A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery","sponsor":"Blaze Bioscience Inc.","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02496065/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"blz-100","kind":"drug","name":"Tozuleristide","route":"/drugs/blz-100/"}],"company":[{"id":"blaze-bioscience","kind":"company","name":"Blaze Bioscience","route":"/companies/blaze-bioscience/"}]}}